[Diagnosis of and therapy for hepatocellular carcinoma]
Insights
These S3-level interdisciplinary guidelines offer evidence-based diagnosis and therapy strategies for hepatocellular carcinoma (HCC). They aim to improve patient care, quality of life, and reduce mortality for HCC patients.
Area of Science:
- Hepatobiliary Medicine
- Oncology
- Evidence-Based Medicine
Context:
- Hepatocellular carcinoma (HCC) diagnosis and therapy present significant challenges.
- Existing healthcare practices require updated, evidence-based guidance.
- Interdisciplinary collaboration is crucial for optimal HCC management.
Purpose:
- To provide scientifically rigorous and current diagnostic and therapeutic procedures for HCC patients.
- To guide management for all stages of HCC, including recurrent and metastatic disease.
- To support healthcare professionals in advising patients on specialist procedures, side effects, and outcomes.
Summary:
- The S3-level guidelines consolidate evidence and expert consensus for HCC management.
- They detail procedures for diagnosis, therapy, and rehabilitation.
- Explanatory texts facilitate informed patient consultations by non-specialists.
Impact:
- Improvement in the diagnosis and treatment of hepatocellular carcinoma.
- Foundation for personalized, high-quality HCC therapy.
- Reduction in HCC-related morbidity and mortality, enhancing patient quality of life.
Abstract:
The interdisciplinary guidelines at the S3 level on the diagnosis of and therapy for hepatocellular carcinoma (HCC) constitute an evidence- and consensus-based instrument that is aimed at improving the diagnosis of and therapy for HCC since these are very challenging tasks. The purpose of the guidelines is to offer the patient (with suspected or confirmed HCC) adequate, scientifically based and up-to-date procedures in diagnosis, therapy and rehabilitation. This holds not only for locally limited or focally advanced disease but also for the existence of recurrences or distant metastases. Besides making a contribution to an appropriate health-care service, the guidelines should also provide the foundation for an individually adapted, high-quality therapy. The explanatory background texts should also enable non-specialist but responsible colleagues to give sound advice to their patients concerning specialist procedures, side effects and results. In the medium and long-term this should reduce the morbidity and mortality of patients with HCC and improve their quality of life.
More Related Videos
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Hepatitis
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Cirrhosis I: Introduction
